EUVIMEDEUVIMED entdecken
Fallbericht

CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia

Anivarya Kumar, Amit Goldberg, Laura Alder, Anahid Hamparsumian

Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)

DOI: 10.6004/jnccn.2025.7370 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Anivarya Kumar und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1Duke University Medical Center, Durham, NC. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • 1Duke University Medical Center, Durham, NC.
  • 2Duke Cancer Institute, Duke University Medical Center, Durham, NC.

Zitieren

APA

Kumar, A., Goldberg, A., Alder, L., & Hamparsumian, A. (2026). CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7370

Vancouver

Kumar A, Goldberg A, Alder L, Hamparsumian A. CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7370

BibTeX
@article{Kumar2026,
  author = {Kumar, Anivarya and Goldberg, Amit and Alder, Laura and Hamparsumian, Anahid},
  title = {CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {3.5},
  doi = {10.6004/jnccn.2025.7370}
}
Kostenlos starten →